Medical and surgical interventions for the prevention of preterm birth

References

• Tucker J, McGuire W. Epidemiology of preterm birth. Br. Med. J.329(7467), 675–678 (2004).
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. In:National Vital Statistics Reports. National Center for Health Statistics, MD, USA 52(10) (2003).
   Google Scholar
• Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. Br. Med. J.332(7547), 937–939 (2006).
   PubMed Web of Science ®Google Scholar
• McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N. Engl. J. Med.312, 82–90 (1985).
   PubMed Web of Science ®Google Scholar
• Hack M, Fanaroff AA. Outcomes of extremely immature infants – a perinatal dilemma. N. Engl. J. Med.329, 1649–1650 (1993).
   PubMed Web of Science ®Google Scholar
• Vidaeff A, Ramin S. From concept to practice: the recent history of preterm delivery prevention. Part I. Cervical competence. Am. J. Perinatol.23(1), 3–13 (2006).
   PubMed Web of Science ®Google Scholar
• Vidaeff A, Ramin S. From concept to practice: the recent history of preterm delivery prevention. Part II. Subclinical infection and hormonal effects. Am. J. Perinatol.23(2), 75–84 (2006).
   PubMed Web of Science ®Google Scholar
• Owen J, Yost N, Berghella V et al. Can shortened midtrimester cervical length predict very early spontaneous preterm birth? Am. J. Obstet. Gynecol.191, 298–303 (2004).
   PubMed Web of Science ®Google Scholar
• Iams JD, Goldenberg RL, Meis PJ et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N. Engl. J. Med.334(9), 567–572 (1996).
   PubMed Web of Science ®Google Scholar
• Shirodkar JN. A new method for operative treatment for habitual abortions in the second trimester of pregnancy. Antiseptic299–300 (1955).
   Google Scholar
• MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br. J. Obstet. Gynaecol.100, 516–523 (1993).
   PubMedGoogle Scholar
• Lazar P, Gueguen S, Dreyfus J, Renaud R, Pontonnier G, Papiernik E. Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br. J. Obstet. Gynaecol.91(8), 731–735 (1984).
   PubMedGoogle Scholar
• Rush RW, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A. A randomized controlled trial of cervical cerclage in women at high-risk of spontaneous preterm delivery. Br. J. Obstet. Gynaecol.91(8), 724–730 (1984).
   PubMedGoogle Scholar
• Dor J, Shalev J, Mashiach S, Blankstein J, Serr DM. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following induced ovulation. Gynecol. Obstet. Invest.13(1), 55–60 (1982).
   PubMed Web of Science ®Google Scholar
• Ezechi OC, Kalu BK, Nwokoro CA. Prophylactic cerclage for the prevention of preterm delivery. Int. J. Gynaecol. Obstet.85(3), 283–284 (2004).
   PubMed Web of Science ®Google Scholar
• Althuisius SM, Dekker GA, Hummel P, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am. J. Obstet. Gynecol.185(4), 1106–1112 (2001).
   PubMed Web of Science ®Google Scholar
• Rust OA, Atlas RA, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am. J. Obstet. Gynecol.185(5), 1098–1105 (2001).
   PubMed Web of Science ®Google Scholar
• To MS, Alfirevic Z, Heath VC et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet363(9424), 1849–1853 (2004).
   PubMed Web of Science ®Google Scholar
• Berghella V, Odibo A, Tolosa J. Cerclage for prevention of preterm birth in women with short cervix found on transvaginal ultrasound examination: a randomized trial. Am. J. Obstet. Gynecol.191(4), 1311–1317 (2004).
   PubMed Web of Science ®Google Scholar
• Althuisius SM, Dekker GA, van Geijn HP, Bekedam DJ, Hummel P. Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): study design and preliminary results. Am. J. Obstet. Gynecol.183(4), 823–829 (2000).
   PubMed Web of Science ®Google Scholar
• Berghella V, Odibo AO, To MS, Rust OA, Althuisus SM. Cerclage for short cervix on ultrasonography. Meta-analysis of trials using individual patient-level data. Obstet. Gynecol.106(1), 181–189 (2005).
   PubMed Web of Science ®Google Scholar
• Hollier LM. Preventing preterm birth: what works, what doesn’t. Obstet. Gynecol. Surv.60(2), 124–131 (2005).
   PubMed Web of Science ®Google Scholar
• Meis PJ, Goldenberg RL, Mercer B et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am. J. Obstet. Gynecol.173(4), 1231–1235 (1995).
   PubMed Web of Science ®Google Scholar
• Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet. Gynecol.80(2), 173–177 (1992).
   PubMed Web of Science ®Google Scholar
• Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N. Engl. J. Med.333(26), 1732–1736 (1995).
   PubMed Web of Science ®Google Scholar
• Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am. J. Obstet. Gynecol.171(2), 345–349 (1994).
   PubMed Web of Science ®Google Scholar
• McDonald HM, O’Loughlin JA, Vigneswaran R et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br. J. Obstet. Gynaecol.104(12), 1391–1397 (1997).
   PubMedGoogle Scholar
• Carey JC, Klebanoff MA, Hauth JC et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. N. Engl. J. Med.342(8), 534–540 (2000).
   PubMed Web of Science ®Google Scholar
• Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet361, 983–988 (2003).
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D. Preterm labour – is bacterial vaginosis involved? S. Afr. Med. J.92(3), 231–234 (2002).
   PubMed Web of Science ®Google Scholar
• McGregor JA, French JI, Jones W et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am. J. Obstet. Gynecol.170(4), 1048–1059 (1994).
   PubMed Web of Science ®Google Scholar
• Joesoef MR, Hillier SL, Wiknjosastro G et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am. J. Obstet. Gynecol.173(5), 1527–1531 (1995).
   PubMed Web of Science ®Google Scholar
• Rosenstein IJ, Morgan DJ, Lamont RF et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect. Dis. Obstet. Gynecol.8(3–4), 158–165 (2000).
   PubMedGoogle Scholar
• Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br. J. Obstet. Gynaecol.106, 652–657 (1999).
   PubMedGoogle Scholar
• Kurkinen-Raty M, Vuopala S, Koskela M et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br. J. Obstet. Gynecol.107(11), 1427–1432 (2000).
   Google Scholar
• Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartum infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet. Gynecol.97, 643–648 (2001).
   PubMed Web of Science ®Google Scholar
• Guaschino S, Ricci E, Franchi M et al. Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur. J. Obstet. Gynecol. Reprod. Biol.110(2), 149–152 (2003).
   PubMed Web of Science ®Google Scholar
• Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br. Med. J.329, 371 (2004).
   PubMed Web of Science ®Google Scholar
• Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet. Gynecol.101, 16–22 (2003).
   Google Scholar
• Leitich H, Brunbauer M, Bodner-Adler B, Kaider A, Egarter C, Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am. J. Obstet. Gynecol.188(3), 752–758 (2003).
   PubMed Web of Science ®Google Scholar
• McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. (1), CD000262 (2005).
   Google Scholar
• Klebanoff MA, Carey JC, Hauth JC et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic trichomonas vaginalis infection. N. Engl. J. Med.345(7), 487–493 (2001).
   PubMed Web of Science ®Google Scholar
• Kigozi GG, Brahmbhatt H, Wabwire-Mangen F et al. Treatment of trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol.189, 1398–1400 (2003).
   PubMed Web of Science ®Google Scholar
• Andrews WW, Sibai BM, Thom EA et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet. Gynecol.101(5), 847–855 (2003).
   PubMed Web of Science ®Google Scholar
• Shennan A, Crawshaw S, Briley A et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. Br. J. Obstet. Gynaecol.113(1), 65–74 (2006).
   Google Scholar
• Goldenberg RL, Mwatha A, Read JS et al. The HPTN 024 study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am. J. Obstet. Gynecol.194(3), 650–661 (2006).
   PubMed Web of Science ®Google Scholar
• Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. Am. J. Obstet. Gynecol.194(3), 617–623 (2006).
   PubMed Web of Science ®Google Scholar
• MacDonald PC, Casey ML. Preterm birth. Scientific American3(2), 42–51 (1996).
   Google Scholar
• Challis JRG. Sharp increases in free circulating oestrogens immediately before parturition in sheep. Nature229, 208 (1971).
   PubMed Web of Science ®Google Scholar
• Casey ML, MacDonald PC. The role of a fetal–maternal paracrine system in the maintenance of pregnancy and the initiation of parturition. In: Fetal and Neonatal Development. Jones CT (Ed.). Perinatology Press, NY, USA 521–533 (1988).
   Google Scholar
• Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br. J. Obstet. Gynaecol.97, 149–154 (1990).
   PubMedGoogle Scholar
• Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br. J. Obstet. Gynaecol.96, 265–274 (1989).
   PubMedGoogle Scholar
• Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet. Gynecol.105, 273–279 (2005).
   PubMed Web of Science ®Google Scholar
• Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol.194, 1234–1242 (2006).
   PubMed Web of Science ®Google Scholar
• Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth (Cochrane Review). Cochrane Database Syst. Rev.1CD004947 (2006).
   Google Scholar
• Meis PJ, Kelbanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17-α-hydroxyprogesterone caproate. N. Engl. J. Med.348(13), 2379–2385 (2003).
   PubMed Web of Science ®Google Scholar
• da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled trial. Am. J. Obstet. Gynecol.18, 419–424 (2003).
   Google Scholar
• Kenyon SL, Taylor DJ, Tarnow-Mordi W et al. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomized trial. Lancet357, 989–994 (2001).
   PubMed Web of Science ®Google Scholar
• King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, UK (2003).
   Google Scholar
• Thorp JM Jr, Hartmann KE, Berkman ND et al. Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am. J. Obstet. Gynecol.186(3), 587–592 (2002).
   PubMed Web of Science ®Google Scholar
• Berkman ND, Thorp JM Jr, Lohr KN et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am. J. Obstet. Gynecol.188(6), 1648–1659 (2003).
   PubMed Web of Science ®Google Scholar
• Merkatz IR, Peter JB, Barden TP. Ritodrine hydroxhloride: a betamimetic agent for use in preterm labor: evidence of efficacy. Obstet. Gynecol.56, 7–12 (1980).
   PubMed Web of Science ®Google Scholar
• Larsen JF, Eldon K, Lange AP et al. Ritodrine in the treatment of preterm labor: second Danish multicenter study. Obstet. Gynecol.67, 607–613 (1986).
   PubMed Web of Science ®Google Scholar
• Leveno KJ, Klein VR, Guzick DS, Young DC, Hankins GD, Williams ML. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1, 1293–1296 (1986).
   PubMed Web of Science ®Google Scholar
• Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the β-adrenergic agonist ritodrine. N. Engl. J. Med.327, 308–312 (1992).
   PubMed Web of Science ®Google Scholar
• Guinn DA, Goepfert AR, Owen J, Brumfield C, Hauth JC. Management options in women with preterm uterine contractions: a randomized clinical trial. Am. J. Obstet. Gynecol.177(4), 814–818 (1997).
   PubMed Web of Science ®Google Scholar
• Hesseldahl H. A Danish multicenter study on ritodrine in the treatment of pre-term labour. Dan. Med. Bull.26, 116–118 (1979).
   PubMedGoogle Scholar
• Fox MD, Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. Neonatal morbidity between 34 and 37 weeks’ gestation. J. Perinatol.13(5), 349–353 (1993).
   PubMedGoogle Scholar
• Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am. J. Obstet. Gynecol.163, 767–772 (1993).
   Google Scholar
• King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour: a systematic review of the evidence and a protocol for administration of nifedipine. Aust. NZ J. Obstet. Gynaecol.43(3), 192–198 (2003).
   PubMed Web of Science ®Google Scholar
• Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX – a randomized, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. Br. J. Obstet. Gynaecol.112(6), 725–730 (2005).
   Google Scholar
• Romero R, Sibai BM, Sanchez-Ramos L et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am. J. Obstet. Gynecol.182(5), 1173–1183 (2000).
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am. J. Obstet. Gynecol.181(2), 484–490 (1999).
   PubMed Web of Science ®Google Scholar
• Meirowitz NB, Ananth CV, Smulian JC, Vintzileos AM. Value of maintenance therapy with oral tocolytics: a systematic review. J. Matern. Fetal Med.8(4), 177–183 (1999).
   PubMedGoogle Scholar